Theoretical Analysis of the Performance of Glucose Sensors with Layer-by-Layer Assembled Outer Membranes

Abstract

The performance of implantable electrochemical glucose sensors is highly dependent on the flux-limiting (glucose, H2O2, O2) properties of their outer membranes. A careful understanding of the diffusion profiles of the participating species throughout the sensor architecture (enzyme and membrane layer) plays a crucial role in designing a robust sensor for both in vitro and in vivo operation. This paper reports the results from the mathematical modeling of Clark's first generation amperometric glucose sensor coated with layer-by-layer assembled outer membranes in order to obtain and compare the diffusion profiles of various participating species and their effect on sensor performance. Devices coated with highly glucose permeable (HAs/Fe3+) membranes were compared with devices coated with PSS/PDDA membranes, which have an order of magnitude lower permeability. The simulation showed that the low glucose permeable membrane (PSS/PDDA) sensors exhibited a 27% higher amperometric response than the high glucose permeable (HAs/Fe3+) sensors. Upon closer inspection of H2O2 diffusion profiles, this non-typical higher response from PSS/PDDA is not due to either a larger glucose flux or comparatively larger O2 concentrations within the sensor geometry, but rather is attributed to a 48% higher H2O2 concentration in the glucose oxidase enzyme layer of PSS/PDDA coated sensors as compared to HAs/Fe3+ coated ones. These simulated results corroborate our experimental findings reported previously. The high concentration of H2O2 in the PSS/PDDA coated sensors is due to the low permeability of H2O2 through the PSS/PDDA membrane, which also led to an undesired increase in sensor response time. Additionally, it was found that this phenomenon occurs for all enzyme thicknesses investigated (15, 20 and 25 nm), signifying the need for a holistic approach in designing outer membranes for amperometric biosensors.

Enzyme Biosensors for Biomedical Applications: Strategies for Safeguarding Analytical Performances in Biological Fluids

“…As evident in Equations (1) and (2), in first generation biosensors optimum analytical performance can be attained when the ratio of target analyte to O 2 is <1 [ 112 , 113 ]. In some in vivo applications this ratio is not met as in the detection of extracellular glucose in subcutaneous tissue where glucose/O 2 ratio is around 30 under physiological conditions.…”

A Low-Power Miniaturized Microelectronic System for Continuous Glucose Monitoring

“…The glucose sensor utilized in this platform is a 3-electrode amperometric device based on Clark's first generation sensor design, 16 which employs the glucose oxidase (GOx) enzyme as the sensing scheme. The flavin adenine dinucleotide (FAD) redox cofactor of GOx oxidizes glucose to glucarolactone, shown below in Eqs.…”

Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants

“…Biosensors, defined as analytical devices that detect biological analytes, have progressed in their development and miniaturization such that fully-implantable sensors (usually in the subcutaneous tissue) will become a reality in the near future [1][2][3][4][5][6][7][8][9][10][11][12]. These sensors will provide real-time, continuous monitoring of analytes, such as glucose, which are currently being monitored intermittently.…”